SCHEMBL13543251

SCHEMBL13543251

CN(C)S(=O)(=O)c1ccc(C(=O)C(C)(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ MAPT P10636 2/20 0.51
▸ TRPV4 Q9HBA0 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.49
▸ ALDH1A1 P00352 4/20 0.48
▸ LMNA P02545 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ ABCC9 O60706 1/20 0.48
▸ ABCC8 Q09428 1/20 0.48
▸ KCNJ11 Q14654 1/20 0.48
▸ KCNJ8 Q15842 1/20 0.48
▸ GAA P10253 1/20 0.47
▸ ATM Q13315 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.44
▸ POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13543237 0.81 HTT (0.66) SMN1; SMN2MAPTHSD17B10ALDH1A1LMNA
SCHEMBL5249012 0.80 SMN1; SMN2 (0.57) SMN1; SMN2MAPTTRPV4HSD17B10ALDH1A1
SCHEMBL13543249 0.80 MEN1 (0.62) SMN1; SMN2MAPTHSD17B10ALDH1A1LMNA
SCHEMBL13543262 0.79 MAPT (0.68) MAPTALDH1A1LMNAHTTL3MBTL1
SCHEMBL5561006 0.79 SMN1; SMN2 (0.56) SMN1; SMN2MAPTTRPV4HSD17B10ALDH1A1
SCHEMBL34672 0.79 ALDH1A1 (0.66) SMN1; SMN2MAPTHSD17B10ALDH1A1LMNA
SCHEMBL13543242 0.79 LMNA (0.46) SMN1; SMN2MAPTALDH1A1LMNANPC1
SCHEMBL13543239 0.79 ENPP2 (0.50) —
SCHEMBL10001214 0.78 CA9 (0.69) SMN1; SMN2ALDH1A1LMNAABCC9ABCC8
SCHEMBL23091236 0.77 LMNA (0.39) MAPTALDH1A1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 — — US disclosed
Send feedback